Division of Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland; and.
Division of Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland; and International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Blood. 2016 Jun 23;127(25):3175-9. doi: 10.1182/blood-2015-09-669929. Epub 2016 May 4.
In steady-state adult hematopoiesis, most hematopoietic stem cells (HSCs) are in the resting phase of the cell cycle. Upon enhanced hematopoietic demand, HSCs can be induced to divide and self-renew or differentiate. However, the cell-extrinsic signals inducing HSC cycling remain to be elucidated. Using in vivo high-resolution single HSC divisional tracking, we directly demonstrate that clinically applied thrombopoietin receptor but not granulocyte colony-stimulating factor (G-CSF) receptor agonists drive HSCs into self-renewing divisions leading to quantitative expansion of functional HSC as defined by their in vivo serial multilineage and long-term repopulating potential. These results suggest that thrombopoietin mimetics might be applicable to expand HSCs in vivo and to sensitize thrombopoietin receptor-expressing HSCs to cell cycle-dependent cytotoxic agents.
在成人稳态造血中,大多数造血干细胞(HSCs)处于细胞周期的静止期。在造血需求增加时,HSCs 可以被诱导分裂、自我更新或分化。然而,诱导 HSC 周期的细胞外信号仍有待阐明。通过体内高分辨率单个 HSC 分裂追踪,我们直接证明,临床应用的血小板生成素受体激动剂而不是粒细胞集落刺激因子(G-CSF)受体激动剂可诱导 HSCs 进行自我更新分裂,从而导致功能性 HSC 的定量扩增,其定义为体内连续多谱系和长期重建潜能。这些结果表明,血小板生成素模拟物可能适用于体内扩增 HSCs,并使表达血小板生成素受体的 HSCs 对细胞周期依赖性细胞毒性药物敏感。